[{"Assets_0_Q2_USD":18805000.0,"CommonStockSharesOutstanding_0_Q2_shares":17219300.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-1195000.0,"NetIncomeLoss_1_Q2_USD":-1059000.0,"NetIncomeLoss_2_Q2_USD":-2418000.0,"StockholdersEquity_0_Q2_USD":17823000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190812"}]